SpaceGen made its debut at the international Medlab Middle East 2024 exhibition, showcasing its abundant product prowess.

SpaceGen made its debut at the international Medlab Middle East 2024 exhibition, showcasing its abundant product prowess.

Dubai, a city that defies description with its beauty, hosted the Arab International Medical Laboratory Instruments and Equipment Exhibition (Medlab Middle East) from February 5th to 8th, 2024. This international industry event showcased a range of the latest and most innovative medical technologies and cutting-edge scientific products, attracting broad attention from innovative leaders and healthcare professionals worldwide.

As scheduled, SpaceGen attended this premier event in the global medical device industry, shining brightly at booth #Z7.C37, engaging with global clients and partners to discuss the latest industry trends and challenges.

This time, SpaceGen unveiled its integrated tumor gene testing product solutions, covering a wide range of testing areas from front-end sample processing to end-point detection, including tumor early screening, companion diagnostics, recurrence monitoring, genetic disease testing, infectious disease testing, and more. These products represent SpaceGen's leading position and innovative research and development capabilities in the field of in vitro diagnostics. Upon display, they attracted numerous visitors who stopped by to negotiate deals.

Facing inquiries from visiting clients, the SpaceGen team actively explained and highlighted the product advantages on-site. At the same time, they detailed SpaceGen's "quality-first" service system from the perspective of the customers. We have earned high praise and recognition from numerous clinical healthcare professionals, medical practitioners, and distribution partners with our combination of "high-level service + high-quality products".

We thank our customers for their trust in our products and services, and we will strive even harder to provide more comprehensive, systematic, faster, and more convenient products. Anchored in China while aiming at the world, SpaceGen's global market expansion continues unabated. In the future, we will continue to delve deeper into the field of tumor gene testing, continuously enhancing our product strength, and writing the story of globalization.